NIH Grants & Funding /
Participating Organization: National Institute on Drug Abuse (NIDA)
| FOA Number | Co-Funders | Title | Clinical Trial | Activity Code | Application Due Date |
|---|---|---|---|---|---|
| RFA-DA-22-045 | National Center for Complementary and Integrative Health (NCCIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Dental and Craniofacial Research (NIDCR), National Institute on Aging (NIA), National Institute on Drug Abuse (NIDA) | HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic | Not allowed | R21 | ClosedMarch 10, 2022 |
| PAR-23-158 | National Institute on Drug Abuse (NIDA) | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) | Basic Experimental Studies with Humans are required. | R61/R33 | June 21, 2023 | October 09, 2023 | March 13, 2024 | June 20, 2024 | October 09, 2024 | March 13, 2025 | June 20, 2025 | October 09, 2025 | March 13, 2026 |
| RFA-DA-24-024 | National Institute on Drug Abuse (NIDA) | Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) | Required | R61/R33 | ClosedNovember 02, 2023 |